Catheter Precision (VTAK) Gross Profit (2017 - 2026)

Catheter Precision's (VTAK) quarterly Gross Profit came in at $390000.0 in Q1 2026, up 195.45% year-on-year from $132000.0 in Q1 2025, and up 78.9% on a QoQ basis from $218000.0 in Q4 2025.

Catheter Precision (VTAK) Gross Profit (2017 - 2026) Analysis & Trends

Catheter Precision (VTAK) has 10 years of Gross Profit data on file, last reported at $390000.0 in Q1 2026.

  • On a quarterly basis, Gross Profit rose 195.45% year-over-year to $390000.0 in Q1 2026; TTM through Mar 2026 was $1.0 million, a 134.18% increase from a year earlier, with the FY2025 full-year figure at $756000.0, up 100.0% from the prior year.
  • Gross Profit for Q1 2026 stood at $390000.0, up from $218000.0 in the prior quarter.
  • Over the last five years, Gross Profit for VTAK reached as high as $390000.0 in Q1 2026 and fell as low as -$86000.0 in Q1 2022.
  • Historically, Gross Profit has averaged $119266.7 across 5 years, with a median of $121000.0 in 2023.
  • Across the five-year window, Gross Profit jumped 245.9% in 2023 and plunged 32.28% in 2024, its largest moves.
  • Year by year, Gross Profit stood at -$61000.0 in 2022, then soared by 298.36% to $121000.0 in 2023, then climbed by 14.05% to $138000.0 in 2024, then surged by 57.97% to $218000.0 in 2025, then soared by 78.9% to $390000.0 in 2026.
  • Per Business Quant data, the three most recent Gross Profit figures were $390000.0 in Q1 2026, $218000.0 in Q4 2025, and $208000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Catheter Precision 0.80 -811,999.20 390,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 390,000.00
Mar 31, 2026 390,000.00
Dec 31, 2025 218,000.00
Dec 31, 2025 218,000.00
Sep 30, 2025 208,000.00
Sep 30, 2025 208,000.00
Jun 30, 2025 198,000.00
Jun 30, 2025 198,000.00
Mar 31, 2025 132,000.00
Mar 31, 2025 132,000.00
Dec 31, 2024 138,000.00
Dec 31, 2024 138,000.00
Sep 30, 2024 86,000.00
Sep 30, 2024 86,000.00
Jun 30, 2024 77,000.00
Jun 30, 2024 77,000.00
Mar 31, 2024 77,000.00
Mar 31, 2024 77,000.00
Dec 31, 2023 121,000.00
Dec 31, 2023 121,000.00